請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62835
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鍾國彪 | |
dc.contributor.author | Hung-Chi Chen | en |
dc.contributor.author | 陳宏基 | zh_TW |
dc.date.accessioned | 2021-06-16T16:11:55Z | - |
dc.date.available | 2014-03-04 | |
dc.date.copyright | 2013-03-04 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-02-18 | |
dc.identifier.citation | Ahlbom HE (1941) The results of radiotherapy of hypopharyngeal cancer at the Radium-hemmet, Stockholm, 1930-1939. Acta Raiologica 22: 155-171.
Arbes SJ Jr, Olshan AF, Caplan DJ, et al (2009): Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States) Cancer Causes Control 1999;10:513-523. Auerbach AD, Hilton JF, Maselli J, Pekow PS, Rothberg MB, Lindenauer PK (2009). Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery. Ann Int Med 150(10):696-704. Bahadur S, Iyer S, Kacker SK (1985). The thyroid gland in the management of carcinoma of the larynx and laryngopharynx J Laryngology Otology 99: 1251-1253. Barringer DA, Hutcheson KA, Sturgis EM, Kies MS, Lewin JS (2009). Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck 31(5): 611-617. Begg CB, Cramer LD, Hoskins WJ, Brennan MF (1998). Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280: 1747-1751. Bell CB, Schnipper JL, Auerbach AD, Kaboli PJ, Wtterneck TB, Gonzales DV, Arora VM, Zhang JX, Meltzer DO (2008) Association of Communication between hospital-based physicians and primary care providers with patient outcomes. J Gen Intern Med 24(3): 381-386. Billingsley KG, Morris AM, Dominitz JA, Matthews B, Dobie S, Barlow W, Wright GE, Baldwin LM (2007). Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery. Understanding the volume-outcome relationship. Arch Surg 142: 23-31. Birkmeyer JD, SunYT, Wong SL, Stukel TA(2007). Hospital volume and late survival after cancer surgery. Ann Surg 245(5): 777-783. Boscoe FP, CJ, Henry KA, Goldberg DW, Shahabi K, Elkin EB, Ballas LK, Cockburn M. (2011). Geographic proximity to treatment for early stage breast cancer and likelihood of mastectomy. The Breast 20(4):324-328. Bova R, Goh R, Poulson M, Coman WB (2005). Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 115(5): 864-869. Braakhuis BJM, Visser O, Leemans CR (2009). Oral and oropharyngeal cancer in the Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncology 45: e85-e89. Caliendo M, Kopeinig S (2008). Some practical guidance for the implementation of propensity score matching. J Economic Surveys 22(1): 31-72. Campbell SM, Hann M, Hacker J, Burns C, Oliver D, Thapar A, et al (2001). Identifying predictors of high quality care in English general practice: Observational study. Brit Med J 323(7316): 784-787. Ceylan A, Koybasioglu A, Yilmaz M, Uslu S, Asal K, Inal E (2004). Thyroid gland invasion in advanced laryngeal and hypopharyngeal carcinoma. Kulak Burun Bogaz Ihtis Derg.13(1-2):9-14. Chan SC, Lin CY, Ng SH, Chang JT, Wang HM, Liao CT, Lo CW, Yen TC (2010). 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis. Nuclear Med Communications 31:260-265. Chan YW, Ng RWM, Liu LHL, Chung HP, Wei WI (2011). Reconstruction of circumferential pharyngeal defects after tumor resection: Reference or preference. J Plast Reconstr Aesthet Surg, 64(8):1022-1028. Chang MFT, Wang HM, Kang CJ, Huang SF, Lin CY, Fang KH, Chen EYC, Chen IH, Liao CT, Chang JTC (2010). Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary- an experience in Taiwan. Radiation Oncology 5:91-99. Charlson ME, Pompei P, Ales KL, KacKenzie CR (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383. Chauleur C, Gris JC, Laporte S, Rancon F, Varlet M-N, Decousus H, Mismetti P and STRTHEGE Group. (2010) Use of the Delphi method to facilitate antithrombotics prescription during pregnancy. Thromb Res 126(2):88-92. Chen HC, Tang YB, Cheng MH (2001): Reconstruction of the voice after laryngectomy, Clin Plast Surg 28(2):389-402. Chen HC, Mardini S (2003): Voice reconstruction with bowel Transfer. Seminars in Plastic Surgery 17:257-340. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H ( 2001) The development and validation of a dysphagia-specific quality-of –life questionnaire for patients with head and neck cancer. The M.D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg 127: 870-876. Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, Asch SM et al (2009). Adherence to quality indicators and survival in patients with breast cancer. Med Care 47(2): 217-225. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P (2011). The value of a symptom cluster of fatigue, dyspnea and cough in predicting clinical outcomes in lung cancer survivors. J Pain and Symptom Management 42(2): 213-221. Chien CR, Tsai CM, Tang ST, Chung KP, Chiu CH, Lai MS (2008). Quality of care for lung cancer in Taiwan: A pattern of care based on core measures in Taiwan Cancer Database Registry. J Formosa Med Assoc 107(8): 635-643. Chu YT, Ng YY, Wu SC (2010) Comparison of different comorbidity measures for use with administrative data in predicting short and long-term mortality. Health Services Res 10: 140-146. Chung KP, Lai MS, Cheng SH, Tang ST, Huang CC, Cheng AL, Hsieh PC (2008). Organization-based performance measures of cancer care quality: core measure development for breast cancer. European J Cancer Care 17: 5-18. Chung KP, Chang YJ, Lai MS, Kuo RNC, Cheng SH, Chen LT, Tang RP, Liu TW, Shieh MJ (2010). Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan. BMC Health Services Research 10:27-39. Clegg LX, Li FP, Hankey BG, Chu K, Edwards BK (2002). Cancer survival among US whites and minorities—A SEER (surveillance, epidemiology and end results) program population-based study. Arch Int Med 162(17): 1985-1993. Cochran WG (1968). The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24(2): 295-313. Cook C, Brismee JM, Pietrobon R, Sizer P, Hegedus E, Riddle D (2009). Development of a quality checklist using Delphi methods for Prescriptive clinical prediction rules. The QUADCPR. J. Manipulative Physiological Therapeutics 33 (1): 29-41. Couch M, Lai V, Cannon T, et al (2007). Cancer cachexia syndrome in head and neck cancer patients: Part I: Diagnosis, impact on quality of life and survival, and treatment. Head and Neck 29: 401-411. de Carpentier JP, Ryder WDJ, Woolford TJ (1996): Survival times of Provox valves, J Laryngol Otol 10:37-42. Delgado A, Saletti-Cuesta L, Lopez-Fernandez LA, Luna JD, Mateo-Rodriguez I. (2011) Gender and the professional career of primary care physicians in Andalusia (Spain). BMC Health Services Research 11:51. Delsupehe K, Zink I, Lejaegere M, et al (1998). Prospective randomized comparative study of tracheoesophageal voice prosthesis: Blom-Singer versus Provox. The laryngoscope 108:1561-1565. Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, et al (2008). American society of clinical oncology/national comprehensive cancer network quality measures. J Clin Oncol 26(21): 3631-3637. de Souza DLB, Perez MMB, Curado MP (2011). Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiology 35(6): 510-514. Deschler DG, Doherty ET, Reed CG, et al (1994). Tracheoesophageal voice following tubed free radial forearm flap reconstruction of the neopharynx. Ann Otol Rhinol Laryngol 103:929-936. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative detabases. J Clin Epidemiology 45(6): 613-619 D’Hoore WCS, Tilquin C (1993). Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods of Iinformation in Med 32(5): 382-387. Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T, Ardannaz E, Brennan P(2005). Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 103 (11): 2326-33. Dixon E, Armstrong C, Maddern G, Sutherland F, Hemming A, Wei A, et al (2009). Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process. J Surg Res 156(1): 32-38. Department of Health (2009) Death statistics, Taiwan DOH Available from : http://www.doh.gov.tw/CHT2006/DM/DM_2.aspx?now _fod_list_no=10642&class_no=440&level_no=3#. [accessed October 1 2009] Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, Terrell JE. (2009) Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncology 27(12): 1969-1975. Durvasula VS, Mahendran S, Grant JW, Jani P (2005). Cutaneous metastases from a hypopharyngeal malignancy. J Laryngol Otol. 2005 Apr;119(4):319-21. East C, Grant H, Jones B (1992): Tracheal reconstruction using a composite microvascular temporopariental fascia flap and nasal septal graft. J Laryngol Otol 106:741-743. Eddy DM (1998). Performance measurement: problems and solutions. Health Affairs 17(4): 7-25. Ehrenberger K, Wicke W, Piza H, et al (1985): Jejunal grafts for reconstruction a phonatory neoglottis in laryngectomized patients. Arch Otorchinolarygol 242:217-223. El-Jardali F, Saleh S, Ataya N, Jamal D (2011). Design, implementation and scaling up of the balanced scorecard for hospitals in Lebanon: Policy coherence and application lessons for low and middle income countries. Health Policy 103(2-3): 305-314. Elixhauser A et al(1998). Comorbidity measure for use with administrative data. Med Care 36(1): 8-27. Enthoven AC, Tollen LA (2005). Competition in health care: It takes systems to pursue quality and efficiency. Health Affairs 24(5): W5420-5433. Ereno C, Lopez JI, Bilbao FJ (2005). The biphasic pattern of laryngeal and hypopharyngeal adenosquamous carcinoma is retained in lymph node metastasis. Histopathology 46(6): 715-716. Fink A, Kosecoff J, Chassin M, Brook RH (1984) Consensus methods: characteristics and guidelines for use. Am J Pub Health 74(9): 979-983. Finlayson EVA, Goodney PP, Birkmeyer JD (2003). Hospital volume and operative mortality in cancer surgery—A national study. Arch Surg 138(7): 721-725. Frederick L, Greene DLP, Fleming ID DF, Fritz A, Balch CM, Heller DG (2002). AJCC Cancer Staging Manual (6th Edition) The American Joint Committee on Cancer, Springer-Verlag. Gillespie MB, Brodsky MB, Day TA, Lee FS, Martin-Harris B (2004). Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114: 1362-1367. Graham B, Regehr G, Wright JG(2003). Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiology56: 1150-1156. Grimshaw JM, Russell IT(1993). Effect of clinical guidelines on medical practice: a systemic review of rigorous evaluations. Lancet 342(8883): 1317-1322. Guldberg TL, Lauritzen T, Kristensen JK, Vedsted P (2009). The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Family Practice 10:30-37. Guthrie B (2008). Measuring the quality of healthcare systems using composites. Brit Med J 337(7767), a639. Guthrie B, Love T, Fahey T, Morris A, Sullivan F (2005). Control, compare and communicate: designing control charts to summarize efficiently data from multiple quality indicators. Quality and Safety in Health Care 14(6): 450-454. Haley ML, GersztennPC, Heron DE, Chang YF, Atteberry DS, Burton SA (2011). Efficacy and cost-effective analysis of external beam and stereotactic body radiation therapy radiation in the treatment of spine metastasis: a matched-pair analysis. J Neurosurg Spine 14: 537-542. Hannan EL, Wu CT, DeLong ER, Raudenbush SW (2005) Predicting risk-adjusted mortality for CABG surgery-Logistic versus hierarchical logistic models. Med Care 43(7):726-735. Hartz AJ, Krakauer H, Young M et al (1989): Hospital characteristics and mortality rates. N Engl J Med 321:1720-1725. He S, Sun J, Wang Y, Hu Y, Lv Q, Li X, Xu W, Wang S, Yu Z (2011). Complications following gastric pull-up reconstruction for advanced hypopharyngeal or cervical esophageal carcinoma: a 20-year review in a Chinese institute. Am J Otolaryngol 32(4): 275-278. Hoelzer S, Waechter W, Stewart A, Liu R, Schweiger R, Dudeck J (2001). Towards case-based performance measures: uncovering deficiencies in applied medical care. J Evaluation in Clin Practice 7(4): 355-363. Hox JJ, Kreft IGG (1994). Multilevel analysis-methods. Sociological Methods and Research 22(3): 283-299. Ikeda Y, Tsukuda M, Ishitova J, Arai Y, Matsuda H, Katori H, Taguchi T, Yoshida T, Ono M, Sakuma Y, Yagisawa M, Saito N (2005). Four cases of simultaneous triple primary cancers of the hypopharynx, esophagus, and stomach.Otolaryngol Head Neck Surg. 2005 May;132(5):788-93. Jager-Wittenarr H, Dijkstra PU, Vissink A et al.(2007) Critical weight loss in head and neck cancer: prevalence and risk factors at diagnosis: an explorative study. Support Care Cancer 15:1045-1050. Joanne M. Patterson, Elaine McColl, Paul N. Carding, Charles Kelly, Janet A. Wilson (2009). Swallowing performance in patients with head and neck cancer: A simple clinical test. Oral Oncology 45(10): 904-907. Johannes A. Langendijk, Patricia Doornaert, Derek H.F. Rietveld, Irma M. Verdonck-de Leeuw, C Rene Leemans, Ben J Slotman (2009). A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiotherapy and Oncol 90: 189-195. Jones J, Hunter D (1995). Consensus methods for medical and health-services research. Brit Med J 311(7001): 376-380. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, Lee JS (2011). Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2008. Cancer Res Treat 43(1): 1-11. Kadota H, Fukushima J, Nakashima T, Kumamoto Y, Yoshida S,Yasumatsu R, Shiratsuchi H, Morita M (2010). Comparison of salvage and planned pharyngolaryngectomy with jejunal transfer for hypopharyngeal carcinoma after chemoradiotherapy. Laryngoscope 120: 1103-1107. Kahn KL, Rogers WH, Rubenstein LV, Sherwood MJ, Reinisch EJ, Keeler EB, Draper D, Kosecoff J, Brook RH(1990. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. Journal of American Medical Association, 264(15):1969-73. Kambhatla N, Leen TK (1997). Dimension reduction by local principal component analysis. Neural Computation 9(7): 1493-1516. Keeler EB, Kahn KL, Draper D, Sherwood MJ, Rubenstein LV, Reinisch EJ, Kosecoff J, Brook RH(1990).Changes in sickness at admission following the introduction of the prospective payment system. Journal of American Medical Association,264 (15):1962-1968. Kellermann AR, Hackman BB(1988). Emergency department patient “dumping”:an analysis of interhospital transfers to the regional medical center at Memphis, Tennessee. American Journal of Public Health,78 (10):1287-92. Kirk SA, Campbell SM, Kennell-Webb S, Reeves D, Roland M, O.Marshall MN (2003). Assessing the quality of care of multiple conditions in general practice: practical and methodological problems. Quality and Safety in Health Care 12(6): 421-427. Klabunde CN, Potosky AL, Legler JM, Warren JL (2000). Development of a comorbidity index using physician claims data. J Clin Epidemiology 53(12): 1258-1267. Koshima I, Fukuda H, Yamamoto H., Moriguchi T., Soeda S, and Ohta S (1993). Free anterolateral thigh flaps for reconstruction of head and neck defects. Plast. Reconstr. Surg. 92:421. Kovacs AF, Stefenelli U, Seitz O, Middendorp M, Diener J, Sader R, Grunwald F (2009). Positive sentinel lymph nodes are a negative prognostic factor for survival in T1-2 oral/oropharyngeal cancer—A long-term study on 103 patients. Ann Surg. Oncol. 16(2): 233-239. Lang HC, Wu SL. (2011). Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ Doi 10.1007/s10198-011-0307-1 Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Lezzoni LI (2000). Identification of in-hospital complications from claims data. Is it valid? Med Care 38: 785-795. Lee BJ, Chon KM, Kim YS, An WG, Roh HJ, Goh EK, Wang SG (2005). Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line. Chemotherapy. 2005 May;51(2-3):103-10. Lee KD, Lu CH, Chen PT, Chan CH, Lin JT, Huang CE, Chen CC, Chen MC (2009). The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 9: 373-382. Leu YS, Hsiao HT, Chang YC, Lee JC, Chen YJ, Chang YF (2005). Ileocolic free flap reconstruction, concomitant chemotherapy and radiotherapy and assessment of speech and swallowing function during management of advanced cancer of the larynx and hypopharynx: preliminary report. Acta Otolaryngol. 2005 Jun;125(6):642-6. Lewin JS, Barringer DA, May AH, Gillenwater AM, Amold KA, Roberts DB, Yu P (2005). Functional outcomes after circumferential pharyngoesophageal reconstruction.Laryngoscope. 2005 Jul;115(7):1266-71. Li L, Shen C, Wu AC, Li X (2011). Propensity score-based sensitivity analysis method for uncontrolled confounding. Am J Epidemiol174(3):345-353. Lill C, Kornek G, Bachtiary B. Seizer E, Schopper C, Mittlboeck M, Burian M, Wrba F, Thurnher D (2011). Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr ( the Central European J of Medicine) 123 (7-8):215-221. Lin HC, Xirasagar S, Lee HC, Chai CY (2006). Hospital volume and inpatient mortality after cancer-related gastrointestinal resections: The experience of an Asian country. Ann Surg Oncol 13(9): 1182-1188. Lindenauer PK, Behal R, Murray CK, Nsa W, Bratzler DW (2006). Volume, quality of care, and outcome in pneumonia, Ann Int Med 144(4):262-269. MacLehose RF, Kaufman S, Kaufman JS, et al (2005). Bounding causal effects under uncontrolled confounding using counterfactuals. Epidemiology16(4): 548-555. Malin JL, Schneider EC, Apstein AM, Emanuel EJ, Kahn KL (2006). Results of the national initiative for cancer care quality: How can we improve the quality of cancer care in the United States? J Clin Oncol 626-634. Marks JE, Silverman CL (1986) Squamous carcinoma of the hypopharynx. Clin Oncol 5(3): 505-523. Marlin JL, Asch SM, Kerr EA, McGlynn EA (2000). Evaluating the quality of cancer care-Development of cancer care quality indicators for a global quality assessment tool. Cancer 88(3): 7010707. Marlin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL (2006). Results of the national initiative for cancer care quality: How can we improve the quality of cancer care in the United States? J Clin Oncol 24(4): 626-634. Marshall M, Klazinga N, Leatherman S, Hardy C, Bergmann E, Pisco L, et al (2006). OECD Health care quality indicator project. The expert panel on primary care prevention and health promotion. International J for Quality in Health Care 18:21-25. Martens EP, et al (2008). Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods. Pharmacoepidemiology and Drug Safety 17(1): 1-8. McGlynn EA(2003). Selecting common measures of quality and system performance. Medical Care 41(1): 139-147. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A et al (2003). The quality of health care delivered to adults in the United States. New Eng J Med 348(26): 2635-2645. Minagawa T, Maeda T. Shioya R (2011). Esthetic and safe lower lip reconstruction of an asymmetric defect due to cancer resection: A modified Webster method combined with a nasolabial flap. J Oral Maxillofac Surg 69:e256-e259. Mousavi SM, Sundquist J, Hemminki K (2010). Nasopharyngeal and hypopharyngeal carcinoma risk among immigrants in Sweden. Int J Cancer 127: 2888-2892. Murphy BA (2009). Advances in quality of life and symptom management for head and neck cancer patients. Current Opinion in Oncology 21:242-247. Nagano H, Yoshifuku K, Kurono Y( 2010). A useful procedure for observing the cervical esophagus via the hypopharynx. Auris Nasus Larynx 37(6): 713-719. Nakamura K, Shiovama Y, Sasaki T, Ohga S, Saku M, Urashima Y, Yoshitake T, Nakashima T, Kuratomi Y, Komune S, Terashima H, Honda H (2005). Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):680-3. NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in OncologyTM ----Head and Neck Cancers, VI 2006) www.nccn.org Accessed date 2013 Feb. 1. Newhouse JP, Byrne,D.J.(1988). Did medicare’s prospective payment cause lengths of stay to fall? Journal of Health Economics 7:413-16. Nolan T, Berwick DM (2006). All-or-none measurement raises the bar on performance. J Am Med Asso 295(10): 1168-1170. O’Brien SM, DeLong ER, Dokholyan RS, Edwards FH, Peterson ED (2007). Exploring the behavior of hospital composite performance measures-An example from coronary artery bypass surgery. Circulation 116(25): 2969-2975. O’Brien SM, Shahian DM, DeLong ER, Normand SLT, Edwards FH, Ferraris VA et al (2007). Quality measurement in adult cardiac surgery: Part 2- Statistical consideration in composite measure scoring and provider rating. Ann Thorac Surg 83(4): S13-S26. Pfeffer MA, Burdmann EA, Chen CY, et al. (2009) A trial of Darbepoetin Alfa in type 2 diabetes and chronic kidney disease. New Eng J Med 361(21): 2019-2032. Philip EJ, Merluzzi TV, Peterman A, Cronk LB (2009). Measurement accuracy in assessing patient’s quality of life: to weight or not to weight domains of quality of life. Qual Life Res 18: 775-782. Prabhudesai SG, Pramesh CS, Jambhekar NA, Pathak KA, Sanghvi VD. (2004). Epidermotropic cutaneous metastases from hypopharyngeal carcinoma. J Otolaryngol 33(3): 198-200. Price KF(1989).Pricing Medicare’s Diagosis- Related Groups: charge versus estimated costs. Health Care Financing Review 11 (1):79-90. Reeves D, Campbell SM, Adams J, Shekelle PG, Kontopantelis E, Roland MO (2007). Combining multiple indicators of clinical quality-An evaluation of different analytic approaches. Med Care 45(6):489-496. Rogers SN, Ahad SA, Murphy AP (2007). A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncology 43:843-868. Rogers SN (2009). Quality of life for head and neck cancer patients—has treatment planning altered? Oral Oncology 2009; 45:435-439. Romano PS, Roos LL, Jollis JG (1993). Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiology 46(10): 1075-1079. Ronis DL, Duffy SA, Fowler KE, et al (2008). Changes in quality of life over 1 year in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 134:241-248. Rosenbaum PR, Rubin DB (1983). The central role of the propensity score in observational studies for causal effects. Biometrika 70(1): 41-55. Sales AM, deLeon AP, Duppre NC, Hacker MA, Nery JAC, Sarno EN, Penna MLF. (2011). Leprosy among patient contacts: A multilevel study of risk factors. Neglected Tropical Diseases 5 (3): 1-6. Schinagl DAX, Span PN, Oyen WJ, Kaanders JHAM (2011). Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study. Eur J Nucl Med Mol Imaging 38(8): 1449-1458. Scholle SH, Roski J, Adams JL, Dunn DL, Kerr EA, Dugan DP, et al (2008). Benchmarking physician performance: reliability of individual and composite measures. Am J Managed Care 14(12):829-838. Sequist TD, Schneider EC, Odigie EG, Marshall R, Rogers WH, Safran DG (2008). Quality monitoring of physicians: linking patients’ experience of care to clinical quality and outcome. J Gen Intern Med 23(11):1784-1790. Sesterhenn AM, Mandic R, Dunne AA, Wemer JA (2005). Cytokeratin 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies. Anticancer Res. 25(4): 2675-2680. Shwartz M, Ren J, Pekoz E (2008). Estimating a composite measure of hospital quality from the hospital compare database. Med Care 46(8): 778-785. Simon N. Rogers, James S Brown, Julia A. Woolgar, Derek Lowe, Patrick Magennis, Richard J Shaw, David Sutton, Douglas Errington, David Vaughan. (2009) Survival following primary surgery for oral cancer. Oral Oncol 45:201-211. Simunovic M, Rempel E, Theriault ME, Coates A, Whelan T, Holowaty E, et al (2006). Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Canadian J Surg 49(4):251-258. Song R., Gao Y., Song Y., Yu Y., and Song Y (1982). The forearm flap. Clin Plast Surg. 9:21-26. Sprague BL, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA, Remington PL, Newcomb PA. (2011). Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer 117:1542-1551. Stace-Naughton, D.(1999). Coding & reimbursement- the complete picture within health care. Chicago: An American Hospital Association Company, 245-53. Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD (2009). Empirically derived composite measure of surgical performance. Med Care 47(2): 226-233. Sturmer T, Schneeweiss S, Rothman KJ, et al (2007). Performance of propensity score calibration---a simulation study. Am J Epidemiology 165(10):1110-1118. Su YY, Fang FM, Chuang HC, Luo SD, Chien CY (2010). Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy. Head Neck 32(6):780-785. Suarez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, Ferlito A (2010). Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhionolaryngol 267:1811-1824. Taylor J (1998) Access to quality cancer care. Consensus statement. J Clin Oncol 16(4): 1628-1630. Teman S, Bernard J, Dugas C. Trassard M, Gomally E, Soria JC, Faivre S, Luboinsky B, Marandas P, Hainaut P, Lenoir G, Mao L, Janot F (2005). Molecular detection of early-stage laryngopharyngal squamous cell carcinomas. Clin Cancer Res.11 (7): 2547-2551. Urbach DR, Austin PC (2005). Conventional models overestimate the statistical significance of volume-outcome associations, compared with multilevel models. J Clin Epidemiology 58(4): 391-400. Vasilakis V, Patel H, Chen HC (2009) Head and neck reconstruction using cephalic vein transposition in the vessel-depleted neck. Microsurgery 29(8):598-602. von Korff M, Wagner EH, Saunders K (1992). A chronic disease score from automated pharmacy data. J Clin Epidemiology 45(2): 197-203. von Korff M, Koepsell T, Curry S and Diehr P(1992). Multilevel analysis in epidemiologic research on health behavior and outcomes. Am J Epidemiology 135(10): 1077-1082. Wahlberg PCG, Andersson KEH, Biorklund AT, Moller TR. Carcinoma of the hypopharynx: Analysis of incidence and survival in Sweden over a 30-year period. Head and Neck 1998; 20: 714-719. Wiggenaad RGJ, Flierman L, Goossens A, et al (2007). Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol 32:384-390. Woodard TD, Oplatek A, Petruzzelli GJ (2007). Life after total laryngectomy: A measure of long-term survival, function, and quality of life. Arch Otolaryngol Head Neck 133: 526-532. Wynder EL (1975) Toward the prevention of laryngeal cancer. Laryngoscope 85: 1190-1196. Yoshimura RI, Shibuya H, Miura M, Watanabe H, Ayukawa F, Hayashi K, Toda K. (2009). Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiation Oncology Biol Phys 73(3): 772-228. Yoshimoto S, Kawabata K (2005). Retropharyngeal node dissection during total pharyngolaryngectomy for hypopharyngeal cancer. Auris Nasus Larynx. 32(2):163-167. 莊逸洲、陳怡如、史麗珠、陳理(1999)全民健保實施陰道分娩論病例計酬制對醫療資源使用方式的影響-以某財團法人醫學中心為例。中華公共衛生雜誌,18(3):1818-8。 錢慶文、黃三桂(2000)論病例計酬制度對住院日數及醫療費用之影響:以痣瘡切除手術為例。公共衛生26(4):303-16。 錢慶文、邱瓊慧(1999)醫院因應外在環境變化之能力研究:以闌尾切除術實施論病例計制度為例。中華衛誌,18(6):432-44。 陳怡蒼、林恆慶(2004)診斷關係群前瞻性支付制度對醫療品質影響之探討。醫院37(1):16-23。 韓揆(2002)台灣論病例計酬之實施及其變革展望。醫院,35(2):15-27。 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62835 | - |
dc.description.abstract | 背景:
健保的財務日益艱困,個別醫院總額出現許多問題, Tw-DRG又已經開始施行。但是惡性腫瘤之治療並沒有納入DRG之控管,在癌症的診斷與治療方面,使用高科技所花費的經費卻越來越多;包括CT、MRI、顯微重建手術,伽瑪刀,PET,各種放射治療及化學藥物治療等等,在近幾年來快速及廣泛地被應用到口腔癌之診斷與治療,尤其是下咽癌更是如此。我們選擇下咽癌作為研究的對象,同時也是因為它的干擾因素最少,其存活時間通常是直接與疾病本身的控制相關。台灣的下咽癌之罹病率比外國高3.3 倍,治療以後的追蹤比外國容易及完整,但我們過去總是習慣性地因循著國外的方法,過分仰賴別人的研究成果,然而事實上國外之文獻在下咽癌的兩大主軸治療方式之間仍然存在很大的爭議。 目的: 分析台灣究竟對這些病患所做的治療結果其效益如何,選擇最適合我國醫療環境的治療方式,並檢視醫院治療病人之數量對治療後併發症的影響,以作為日後政策決定之參考。這研究的方式及成果甚至可供國內其他癌症管理之借鏡。 資料和方法: 下咽癌的診斷與治療在口腔癌當中是最困難的一種,診斷不易而且治療之難度很高。隨著科技的進步,許多以前認為是診療瓶頸的困難處逐漸被克服。下咽癌之治療方式可以分為兩大類(根治療法與保守療法),目前文獻的缺口就是這兩種治療理念之間的爭議懸而未決。因此我們將針對台灣這兩種治療方式去做深入的研究。由癌症診療資料庫 (CRS-long form) 結合國衛院健保資料庫(NHID) 及死因登記檔去分析2005至2009年之間下咽癌病人的治療方式以及客觀的存活時間、疾病復發、併發症、進食狀況(是否需要管灌飲食)及生活品質;來比較這兩大類治療方式之效益。根據以上資料及多層次分析,可以檢視不同層級的醫院治療病患之數量差異與費用及治療後之合倂症發生率之間的關係。由此可引申出如何控管醫院收治重難症之政策,以減少醫療資源之浪費。下咽癌與其他癌症不同之處是它位於一個樞紐的位置,其治療會造成特殊的問題;因此可以發展一組生理指標來做為客觀評估治療後之生活品質的基礎。 結果: (1) 整體而言,台灣的下咽癌以照護結果及治療後之主觀生活品質來評估都發現只用放化療 (器官保留療法),比手術加輔助性放化療還要好,雖然存活時間比較短。(2) 我們以德菲法發展出一組客觀生理指標來評估下咽癌治療後之生活品質,以這組指標來檢視這兩種治療方式之差異,也是得到相同的結果。(3) 此外我們以多層次分析的統計,發現醫院之下咽癌服務量增加時治療費用有顯著之減少。其他統計方式之結果,顯示醫院之服務量增加時,下咽癌之復發率減少。醫院層級確實影響到治療之併發症的發生率,在醫學中心之併發症減少。 結論: 就目前台灣的醫療環境及我們過去在下咽癌之治療成效而言,建議對一般的下咽癌病患應首先考慮採用放化療;但為了醫學的發展,在醫學中心則可以考慮手術加輔助性放化療,希望我們也能發展到最好的美日水準,之後再普及到一般醫院。 | zh_TW |
dc.description.abstract | Background:
National Health Insurance has encountered a hard situation of financial difficulty in the recent years. Now the policies of global budget and Tw-DRG have been implemented. However, the diagnosis and treatment of malignant tumors are not under the control of Tw-DRG. A lot of medical resources especially advanced technologies ( including CT, MRI, various reconstructive procedures, gamma knife, PET, modern radiation modalities and chemotherapy, etc) have been extensively applied for detection and treatment of oral cancers, especially hypopharyngeal cancer (HPC). Among the oral cancers hypopharyngeal cancer is selected for study because it has minimal confounding factors due to its short survival, which is most closely related to the control of the malignancy. Taiwan has much higher incidence of HPC than the developed countries. However, we always follow the treatment proposed by the developed countries, even though there is still controversy between the two treatment strategies of HPC. The results of our HPC patients in Taiwan are actually unknown. Objects: A study should be carried out for evaluation and comparison between the two options of treatment, and find out the best strategy for our country. This model of research can be applied to improve the management of other cancers. Material and Methods: Hypopharyngeal cancer (HPC) is a special subcategory among oral cancers. It is the most difficult one in diagnosis, also has controversies in treatment. With the advancement in technology, many drawbacks have been overcome. From Taiwan Cancer Database (TCDB) and National Health Insurance Database (NHID) as well as death registry, the data of hypopharyngeal cancer from 2005 to 2009 can be analyzed concerning the differences of the two major treatment modalities (radical surgery with adjuvant chemoradiation, versus organ preservation-intended treatment ), and the efficacy is compared according to the length of survival, time before recurrence, rate of major complications, feeding mode,and subjective evaluation of quality of life. From the above data multilevel analysis can be used to find the relationship between the volume of HPC patients indifferent hospitals versus cost and the rate of major complications after treatment, which is the major source of cost. Because HPC is located at a strategic position, its treatment will cause specific physiologic problems. Thus a series of objective indices can be established as a base to evaluate quality of life. Results: (1) In Taiwan the quality of care and subjective quality of life after treatment of HPC showed better results when the patients were treated with chemoradiation (OPIT) instead of operation with perioperative chemoradiation. However, the time of survival is longer when the patients receive operation and peri-operative chemoradiation. (2)Using Delphi method we developed an objective measurement with 6 physiologic indices for evaluation after treatment of HPC. It showed the same result. (3) Multilevel analysis showed that when the patient volume was increased, the cost would become less. Other analysis showed that when the volume of patient is increased, the recurrence rate becomes less. The complication rate is less in the medical centers. Conclusions: Under the present healthcare situation of Taiwan, it is suggested that chemoradiation alone ( OPIT) should be considered as the first option for most of our HPC patients. However, for continuous development of medicine, operation with peri-operative chemoradiation can be considered in the medical centers, in order to reach the highest international level, then the best treatment can be extended to other hospitals. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T16:11:55Z (GMT). No. of bitstreams: 1 ntu-102-D95843002-1.pdf: 2672645 bytes, checksum: 534c8994f28a76f32cf02f299adad632 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | Acknowledgement i
中文摘要 ii ABSTRACT iv 目 錄 vi LIST OF FIGURES viii LIST OF TABLES ix CHAPTER 1. INTRODUCTION 13 1.1 Background and motivation of research 13 1.2. The importance of this research 15 1.3. The research objects: 18 Chapter 2. LITERATURE REVIEW 19 2.1. Importance of oral cancers (including hypopharyngeal cancer) in Taiwan 19 2.2. Epidemiology of hypopharyngeal cancer--- Why Taiwan has high incidence of HPC? 37 2.3. Care of oral cancer including HPC 39 2.4 Clinical practice guideline for hypopharyngeal cancer 63 2.5. Assessment of quality of life after treatment of HPC 74 2.6. Assessment of comorbidities 81 2.7. Multilevel analysis 84 CHAPTER 3 MATERIALS AND METHOD 85 3.1. Conceptual Framework 85 3.2 Hypothesis 92 3.3. The operational definition of variables in this study 94 3.4. Selection of patients and data collection 99 3.5. Statistical analysis for various hypotheses 105 CHAPTER 4 RESULTS: 108 4.1. Descriptive analysis 108 4.2. Results of KM method, Logistic regression and Cox proportional hazard models 113 4.3. Ho-2a, Ho-2b, the result of multilevel and other statistical analysis 131 4.4. Development of the physiological profile for OBJECTIVE evaluation of quality of life following treatment of HPC 136 CHAPTER 5 DISCUSSION 142 5.1. Discussion on the research and statistical method 142 5.2. Discussion on the dataset--- the limitation by IRB to obtain subjective evaluation of quality of life 143 5.3. Interpretation for study findings 143 5.4. LIMITATION OF THIS SUTDY 153 Chapter 6 CONCLUSION AND RECOMMENDATION 154 6.1. Conclusion 154 6.2. Recommendations 154 REFERENCES 158 APPENDIX 1. The original author of EORTC QLQ-C30 and EORTC QLQ-N&N35 (Chinese Edition) have authorized us to use these tables for the purpose of research, and we have started to use it already. 173 APPENDIX 2: Qestionnaire for Development of Physiological Profile as A Base for Evaluation of Quality of Life Following Treatment----items for specialists in Delphi Method 177 APPENDIX 3. Certificate of Institutional Review Board 187 | |
dc.language.iso | en | |
dc.title | 探討不同治療選項對下咽癌病人照護品質之影響與病人服務量導致治療結果之差異 | zh_TW |
dc.title | Impact of Different Treatment Options on Quality of Care for Hypopharyngeal Cancer and Influence of Patient Volume of Hospitals on the Outcome | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 鄭守夏,蔡銘修,侯勝博,楊銘欽,翁慧卿 | |
dc.subject.keyword | 下咽癌,手術加放射及化療,保守性放射及化療,照護結果,治療數量,醫療費用, | zh_TW |
dc.subject.keyword | hypopharyngeal cancer,radical surgery with adjuvant chemoradiation,chemoradiation alone,quality of care,volume of patients,cost, | en |
dc.relation.page | 188 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-02-18 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2.61 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。